ABC | Volume 112, Nº6, Junho 2019

Artigo Original Carvalhal et al O escore GRACE modula invasividade? Arq Bras Cardiol. 2019; 112(6):721-726 1. McAlister FA. The end of the risk-treatment paradox? a rising tide lifts all boats. J Am Coll Cardiol. 2011;58(17):1766-7. 2. Yan AT, Yan RT, Tan M, Casanova A, Labinaz M, Sridhar K, et al. Risk scores for risk stratification in acute coronary syndromes: Useful but simpler is not necessarily better. Eur Heart J. 2007;28(9):1072-8. 3. Yan AT, Yan RT, Huynh T, Casanova A, Raimondo FE, Fitchett DH, et al. Understanding physicians’ risk stratification of acute coronary syndromes: insights from the Canadian ACS 2 Registry. Arch Intern Med. 2011;169(4):372-8. 4. Weintraub WS. Prediction scores after myocardial infarction: value, limitations, and future directions. Circulation. 2002;106(18):2292-3. 5. De Bondt WFM, Thaler R. Does the stock market overreact? J Finance. 1985;40(3):793-805. 6. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, ArdissinoD, Boersma E, Budaj A, et al. Guidelines for the diagnosis and treatmentofnon-ST-segmentelevationacutecoronarysyndromes.EurHeart J. 2007;28(13):1598-660. 7. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACCGuideline for theManagement of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline . J Am Coll Cardiol. 2014;64(24):e139-228. 8. Roe MT, Peterson ED, Newby LK, Chen AY, Pollack CV Jr, Brindis RG, et al. The influence of risk status on guideline adherence for patients with non-ST-segment elevation acute coronary syndromes. Am Heart J. 2006;151(6):1205-13. 9. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events.. Arch Intern Med. 2003;163(19):2345-53. 10. GRACE Investigators. Rationale and design of the GRACE (Global Registry Of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J . 2001;141(2):190-9. 11. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinaseMBmass for usewith European Society of Cardiology/AmericanCollege of Cardiology consensus recommendations. Clin Chem. 2003;49(8):1331-6. 12. Birkemeyer R, Schneider H, Rillig A, Ebeling J, Akin I, Kische S, et al. Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation. BMC Cardiovasc Disord. 2014 Jun 2;14:71. 13. Mehilli J, King L. Risk-treatment paradox in women with symptomatic coronary artery disease. Clin Res Cardiol Suppl. 2013;8(suppl 1):20-4. 14. Wimmer NJ, Resnic FS, Mauri L, Matheny ME, Piemonte TC, Pomerantsev E, et al. Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J AmHeart Assoc . 2013;2(3):e000174. 15. Pierson DJ. Translating evidence into practice Respir Care. 2009;54(10):1386-401. 16. KoDT, Mamdani M, Alter DA. Lipid-lowering therapywith statins in high-risk elderly patients: the treatment-risk paradox. Jama. 2004;291(15):1864-70. 17. AlexanderKP,NewbyLK,ArmstrongPW,CannonCP,GiblerWB,RichMW,et al.Acutecoronarycare intheelderly,partII:ST-segment-elevationmyocardial infarction: a scientific statement for healthcare professionals from the AmericanHeart Association Council on Clinical Cardiology: in collaboration withtheSocietyofGeriatricCardiology.Circulation.2007;115(19):2570-89. 18. Croskerry P. Frommindless to mindful practice -- cognitive bias and clinical decision making. N Engl J Med. 2013;368(26):2445-8. 19. Hall KH. Reviewing intuitive decision-making and uncertainty: the implications for medical education. Med Educ. 2002;36(3):216-24. 20. Grove WM, Zald DH, Lebow BS, Snitz BE, Nelson C. Clinical versus mechanical prediction: ameta-analysis. Psychol Assess. 2000;12(1):19-30. 21. Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, Steg G, et al. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. AmHeart J. 2009;157(6):1097-105. 22. Manfrini O, Bugiardini R. Barriers to clinical risk scores adoption. Eur Heart J. 2007;28(9):1045-6. 23. Motivala AA, Cannon CP, Srinivas VS, Dai D, Hernandez AF, Peterson ED, et al. Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol. 2011;58(17):1760-5. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 726